Revision: Dec. 1, 2022, 3:39 p.m.
2023 SESSION
23-0430.0
04/05
HOUSE BILL [bill number]
AN ACT exempting dimethyltryptamine from the controlled drug act.
SPONSORS: [sponsors]
COMMITTEE: [committee]
─────────────────────────────────────────────────────────────────
ANALYSIS
This bill exempts dimethyltryptamine from the controlled drug act.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
23-0430.0
04/05
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Three
AN ACT exempting dimethyltryptamine from the controlled drug act.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 New Section; Controlled Drug Act; Exemption for Dimethyltryptamine. Amend RSA 318-B by inserting after section 1-c the following new section:
318-B:1-d Exemption for Dimethyltryptamine. Dimethyltryptamine shall be exempt from the provisions of this chapter.
2 Effective Date. This act shall take effect 60 days after its passage.